Latest News Feed

Inolife is Joining the Fight to Cure Cancer
Inolife Announces Trevor Arsenault as Chief Operating Officer
Inolife Announces the Closing of Its Final Private Placement and the Naming of Dr. John Leombruno to Its Board of Directors
Inolife Enters Into an Agreement With Sanzyme for Gonadotropin Kinetics and Bio-Equivalence Validation
Inolife Announces Formal Signing of Agreement With Namaste, a Leading Medical Cannabis Company
Inolife Appoints Two Renowned Pharmaceutical and Medical Industry Experts to C-Level Executive Positions
Inolife is Getting Closer to Submitting Its Nanojex® Needle-Free Nanoparticle Powder Drug Delivery System to the FDA
Inolife Nominates Dr. Richard Gallo to its Advisory Board
Inolife Has Contracted LOK North America to Spearhead Its ISO 13485 Quality Management System Certification and Initiate Its Health Canada Medical Device Licensing
Inolife Signs LOI With ADW Diabetes to Make Its Inojex Needle-Free Injector Available to Diabetics in USA
Inolife Announces the Commencement of Its Public Listing Process to Meet Growing Demand for Its Needle-Free Injection Technologies.